class action lawsuit

$PMI stock crashed 70% after investigations revealed illicit social media promotion scheme; shareholders urged to join securities fraud lawsuit with April 3, 2026 deadline.

Law Offices of Howard G. Smith filed securities fraud class actions against $SDM, $BRBR, $METC, and $CLEUF, alleging market manipulation and misrepresentation. Lead plaintiff deadline: late March 2026.

NuScale Power faces class action lawsuit alleging it misrepresented partner ENTRA1's nuclear experience and failed to disclose material partnership risks to investors.

Bath & Body Works faces class action lawsuit alleging failure to disclose that marketing strategy wasn't driving customer growth. Stock fell 24.8% after November miss.

Oracle faces class action lawsuit alleging undisclosed AI infrastructure costs and revenue mismatches. Stock declined following missed earnings, delayed data centers, and partner withdrawal.

PayPal shareholders can file claims in securities fraud class action alleging material misstatements about Branded Checkout. Stock plummeted 20.3% following surprise CEO departure and weak earnings.

Schall Law Firm seeks Vistagen investors in class action over alleged false statements regarding fasedienol drug candidate's Phase 3 trial prospects.

DJS Law Group files class action against $FBRT for allegedly overstating dividend prospects and misleading shareholders about $0.355 quarterly distributions.

Class action lawsuit filed against PayPal for allegedly misleading investors. Stock fell over 20% after disappointing Q4 2025 earnings and guidance withdrawal.

Alight stock crashed 38.2% after disappointing Q4 2025 results, prompting a securities fraud investigation by The Rosen Law Firm over alleged misleading disclosures.

Vital Farms stock plummeted 10.8% after disappointing earnings, triggering securities litigation investigation by Rosen Law Firm into alleged misleading disclosures.

Elauwit Connection faces securities investigation after restating financials due to revenue recognition errors in network construction projects, triggering a 6.8% stock decline.

Class action suits filed against Ultragenyx and Mereo BioPharma following failed Phase III trials for setrusumab, with stock prices crashing 42.32% and 87.7% respectively.

Class actions filed against BlackRock TCP and Plug Power over alleged disclosure failures—BlackRock TCP faces NAV understatement claims following 19% decline; Plug Power accused of overstating DOE funding prospects.

CoreWeave faces securities fraud lawsuit alleging misstatements about customer demand capacity, supplier reliance, and financial risks during March-December 2025 class period.

Class action lawsuit filed against Picard Medical for fraudulent stock promotion scheme. Stock crashed 70% to $2.00/share. Investor deadline April 3, 2026.

Class action lawsuit filed against Ardent Health for allegedly inflating receivables. Stock plunged 34% after $43M revenue decrease revealed in Q3 2025.

Robbins Geller files class action against NuScale Power for allegedly misrepresenting commercialization partner ENTRA1's nuclear experience, triggering 12% stock decline.

Class action lawsuit filed against $UGXY alleging securities fraud over misleading setrusumab trial data and OI patient safety disclosures.

Class action lawsuit filed against $BSX alleging executives made false statements about U.S. electrophysiology segment sustainability, concealing competitive pressures and regulatory headwinds.